Chinese drug makers strike a record US$136 billion in out-licensing deals in 2025
Chinese drug makers’ licensing deals more than doubled in 2025 from a year earlier to a record high, propelled by dozens of multibillion-dollar agreements between Hong Kong and mainland China-listed…









